Back to mobile site

H.C. Wainwright Reiterates Buy Rating on Perspective Therapeutics Inc (CATX)

October 3, 2025 6:43 AM EDT Send to a Friend
H.C. Wainwright analyst Robert Burns reiterated a Buy rating and $10.00 price target on Perspective Therapeutics Inc (NYSE: CATX).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login